Status:
RECRUITING
Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures
Lead Sponsor:
Northwestern University
Conditions:
Urologic Diseases
Prostate Obstruction
Eligibility:
MALE
18-89 years
Phase:
NA
Brief Summary
The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate. There is currently no gold-standard laser settings for HoLEP procedures...
Eligibility Criteria
Inclusion
- Males 18-89 who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms, that are typically caused by enlarged prostates
Exclusion
- Prostates measurements over 200g
- Patients who lack decisional capacity
- Patients who are non-english speakers
Key Trial Info
Start Date :
March 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06531473
Start Date
March 4 2024
End Date
August 30 2026
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medicine
Chicago, Illinois, United States, 60611